LIMITED OFFER 🔥 Join our Discord today to unlock 50% off Readever PRO and exclusive reading events

Bad Blood cover

Book summary

Current BestsellerAward-Winner / Critically AcclaimedPerennial Seller

Bad Blood

by John Carreyrou

Inside Elizabeth Holmes's startup, the investors it duped, and the whistleblowers who shut it down

Theranos promised revolutionary blood tests—and delivered fraud

4.8(21k)Published 2018

Topics

StartupsEthicsHealthcareWhistleblowing
Reading companion

How to read Bad Blood with Readever

Read with two notebooks: one for Holmes's persuasion tactics, another for the employees who resisted. Tag every moment when data was manipulated or dissent punished, then translate those points into a compliance checklist using Readever's template library.

Things to know before reading

  • Expect accounts of intimidation, legal threats, and patient harm
  • The book references biotech instrumentation; use context cards for terms like "immunoassay" and "hematology"
  • Legal outcomes (SEC charges, criminal trials) appear toward the end—pace yourself through the procedural detail
  • Consider pairing with recent coverage of AI or biotech regulation for updated parallels
Brief summary

Bad Blood in a nutshell

Wall Street Journal reporter John Carreyrou unravels how Theranos raised billions by claiming it could run hundreds of blood tests from a finger prick. Through interviews with lab workers, regulators, and investors, he reveals faked demos, silenced employees, and a cult of personality around founder Elizabeth Holmes. The book chronicles the legal battles that followed and the systemic vulnerabilities that allowed the scam to flourish.

Key ideas overview

Bad Blood summary of 3 key ideas

Hype without verification endangers both patients and investors.

Key idea 1

Culture sets the tolerance for truth.

Theranos rewarded loyalty over competence, isolating teams and punishing questioners. The lesson: design reporting lines that encourage dissent and protect data integrity.

Key idea 2

Due diligence is a verb, not a vibe.

Carreyrou shows how seasoned investors skipped technical audits because they feared missing out. Use this as motivation to scrutinize claims even when elite names vouch for them.

Key idea 3

Whistleblowers need allies.

Engineers like Tyler Shultz relied on mentors, reporters, and patient advocates to expose the truth. Build your own support network if you ever need to raise alarms.

Start reading Bad Blood for free

Ready to continue? Launch the Readever reader and keep turning pages without paying a cent.

Audit your innovation story before regulators do.

Readever helps you log each governance failure—unchecked boards, NDAs, intimidation—and convert them into safeguards for your own company. Share the highlights as cautionary tales for exec teams.

Deep dive

Key ideas in Bad Blood

Key idea 1

Culture sets the tolerance for truth.

Theranos rewarded loyalty over competence, isolating teams and punishing questioners. The lesson: design reporting lines that encourage dissent and protect data integrity.

Key idea 2

Due diligence is a verb, not a vibe.

Carreyrou shows how seasoned investors skipped technical audits because they feared missing out. Use this as motivation to scrutinize claims even when elite names vouch for them.

Key idea 3

Whistleblowers need allies.

Engineers like Tyler Shultz relied on mentors, reporters, and patient advocates to expose the truth. Build your own support network if you ever need to raise alarms.

Context

What is Bad Blood about?

Carreyrou reveals how Elizabeth Holmes built a $9 billion biotech startup on vaporware. He traces Theranos from its Stanford origins through stealthy demos, Walgreens negotiations, and the eventual cascade of whistleblowers who exposed false lab results endangering patients.

Dive deeper into Bad Blood

Open Readever's reader to highlight passages, ask the AI companion questions, and keep exploring without paying a cent.

Review

Bad Blood review

The book won the Financial Times/McKinsey Business Book of the Year and was lauded for thriller pacing anchored by voluminous evidence. Critics praised Carreyrou for sticking with the story despite aggressive legal intimidation from Holmes and David Boies.

Critical reception: Bestseller in multiple countries, adapted into the Hulu series The Dropout, and frequently cited in ethics courses and boardrooms alike.

  • Winner of the FT/McKinsey Business Book of the Year (2018)
  • One of *The Economist*'s Books of the Year
  • Triggered renewed scrutiny by the SEC and federal prosecutors
  • Sparked the Hulu limited series *The Dropout*
  • Adopted in MBA and med-school curricula as a cautionary tale
Who should read Bad Blood?

Startup founders and investors evaluating due diligence processes

Healthcare administrators overseeing lab quality

Compliance, legal, and HR teams building whistleblower channels

Fans of investigative nonfiction

About the author

John Carreyrou is a Pulitzer Prize-winning investigative reporter formerly with The Wall Street Journal. His work on Theranos earned him George Polk and Gerald Loeb awards. He hosts the "Bad Blood: The Final Chapter" podcast covering the trials.

Discover the Readever catalogue

Build your personalized reading stack

Export a Theranos red-flag checklist for board briefings.

Group highlights by stakeholder—employees, investors, regulators—for quick teaching sessions.

Compare this case with *Empire of Pain* inside Readever's accountability lane.

Share annotated quotes with your ethics or product teams in seconds.

Bad Blood FAQs

Still curious about Bad Blood?

Sign in to Readever to keep reading with AI guidance, instant summaries, and synced notes.

Final summary

Bad Blood proves that mission rhetoric and black turtlenecks cannot replace validated science. It implores readers to ask for primary data, protect truth-tellers, and design boards that know how to say no.

Ready to keep reading smarter?

Start reading Bad Blood for free and unlock personalized book journeys with Readever.